ArticleMolecular therapy. Methods & clinical development2022

VikAD, a Vika site-specific recombinase-based system for efficient and scalable helper-dependent adenovirus production.

Stacia Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.